Paras Healthcare
Q2 consolidated revenue ₹511 Cr (+23%), operating EBITDA ₹120 Cr (+47%), PAT ₹40.3 Cr. Strong operating leverage, but receivables rose to ₹518 Cr, weakening cash conversion (H1 OCF ₹68 Cr). No numeric guidance given.
ALFA Concalls
Every earnings call, live and summarised
Earnings calls
Every Paras Healthcare earnings call we streamed: the live audio and our summary of what management said.
Q2 consolidated revenue ₹511 Cr (+23%), operating EBITDA ₹120 Cr (+47%), PAT ₹40.3 Cr. Strong operating leverage, but receivables rose to ₹518 Cr, weakening cash conversion (H1 OCF ₹68 Cr). No numeric guidance given.
Q2 consolidated revenue ₹511 Cr (+23%), operating EBITDA ₹120 Cr (+47%), PAT ₹40.3 Cr. Strong operating leverage, but receivables rose to ₹518 Cr, weakening cash conversion (H1 OCF ₹68 Cr). No numeric guidance given.
No numeric guidance; beds rise to ~1,800 by H2 FY27, with Gurugram (300) and Ludhiana (500) to follow.
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.